Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 4Terminated 3Unknown 2Recruiting 2Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Weight Loss 1Polycystic Ovary Syndrome 1Neoplasms 1Muscular Atrophy 1Muscle Weakness 1Motor Activity 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × Carnitine × Clear all
NCT03151291 2018-10-16

Effects of WB-EMS and Specific Dietary Supplements on Cancer Patients

University of Erlangen-Nürnberg Medical School

Phase NA Unknown
200 enrolled

Motor Activity, Muscular Atrophy, Neoplasms, Weight Loss, Muscle Weakness

NCT01665547 2013-09-10

Adding L-carnitine in Clomiphene Resistant Polycystic Ovary Improves the Quality of Ovulation and the Pregnancy Outcome

Woman's Health University Hospital, Egypt

Phase 4 Unknown
157 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡